Global Anti-TIGIT Antibody Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Anti-TIGIT Antibody market size was valued at US$ 317.7 million in 2023. With growing demand in downstream market, the Anti-TIGIT Antibody is forecast to a readjusted size of US$ 797.3 million by 2030 with a CAGR of 14.0% during review period.
The research report highlights the growth potential of the global Anti-TIGIT Antibody market. Anti-TIGIT Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-TIGIT Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-TIGIT Antibody market.
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
TIGIT (T cell immunoreceptor with Ig and ITIM domains) is a protein receptor found on various immune cells, including T cells and natural killer (NK) cells. It plays a role in regulating immune responses, and targeting TIGIT has emerged as a potential therapeutic strategy for cancer and autoimmune diseases.
Clinical trials were underway to evaluate the safety and efficacy of anti-TIGIT antibodies either as monotherapy or in combination with other immunotherapies, such as checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies). Promising results were reported from early-stage trials, showing potential benefits in various solid tumors, including lung cancer, melanoma, and gastrointestinal cancers.
The market for anti-TIGIT antibodies was expected to grow as more clinical data became available.
Key Features:
The report on Anti-TIGIT Antibody market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-TIGIT Antibody market. It may include historical data, market segmentation by Type (e.g., Monotherapy, Combination Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-TIGIT Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-TIGIT Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-TIGIT Antibody industry. This include advancements in Anti-TIGIT Antibody technology, Anti-TIGIT Antibody new entrants, Anti-TIGIT Antibody new investment, and other innovations that are shaping the future of Anti-TIGIT Antibody.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-TIGIT Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-TIGIT Antibody product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-TIGIT Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-TIGIT Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-TIGIT Antibody market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-TIGIT Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-TIGIT Antibody market.
Market Segmentation:
Anti-TIGIT Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Anti-TIGIT Antibody market size was valued at US$ 317.7 million in 2023. With growing demand in downstream market, the Anti-TIGIT Antibody is forecast to a readjusted size of US$ 797.3 million by 2030 with a CAGR of 14.0% during review period.
The research report highlights the growth potential of the global Anti-TIGIT Antibody market. Anti-TIGIT Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-TIGIT Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-TIGIT Antibody market.
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
TIGIT (T cell immunoreceptor with Ig and ITIM domains) is a protein receptor found on various immune cells, including T cells and natural killer (NK) cells. It plays a role in regulating immune responses, and targeting TIGIT has emerged as a potential therapeutic strategy for cancer and autoimmune diseases.
Clinical trials were underway to evaluate the safety and efficacy of anti-TIGIT antibodies either as monotherapy or in combination with other immunotherapies, such as checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies). Promising results were reported from early-stage trials, showing potential benefits in various solid tumors, including lung cancer, melanoma, and gastrointestinal cancers.
The market for anti-TIGIT antibodies was expected to grow as more clinical data became available.
Key Features:
The report on Anti-TIGIT Antibody market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-TIGIT Antibody market. It may include historical data, market segmentation by Type (e.g., Monotherapy, Combination Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-TIGIT Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-TIGIT Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-TIGIT Antibody industry. This include advancements in Anti-TIGIT Antibody technology, Anti-TIGIT Antibody new entrants, Anti-TIGIT Antibody new investment, and other innovations that are shaping the future of Anti-TIGIT Antibody.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-TIGIT Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-TIGIT Antibody product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-TIGIT Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-TIGIT Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-TIGIT Antibody market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-TIGIT Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-TIGIT Antibody market.
Market Segmentation:
Anti-TIGIT Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Monotherapy
- Combination Therapy
- Cell Carcinoma
- Solid Tumor
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Merck
- AstraZeneca
- Arcus
- Astellas
- BeiGene
- BMS
- Junshi Biosciences
- Innovent Biologics
- Mereo BioPharma
- Seattle Genetics
- Hengrui Medicine
- Compugen
- Gilead Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size 2019-2030
2.1.2 Anti-TIGIT Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Anti-TIGIT Antibody Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Anti-TIGIT Antibody Market Size by Type
2.3.1 Anti-TIGIT Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
2.4 Anti-TIGIT Antibody Segment by Application
2.4.1 Cell Carcinoma
2.4.2 Solid Tumor
2.5 Anti-TIGIT Antibody Market Size by Application
2.5.1 Anti-TIGIT Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
3 ANTI-TIGIT ANTIBODY MARKET SIZE BY PLAYER
3.1 Anti-TIGIT Antibody Market Size Market Share by Players
3.1.1 Global Anti-TIGIT Antibody Revenue by Players (2019-2024)
3.1.2 Global Anti-TIGIT Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Anti-TIGIT Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY BY REGIONS
4.1 Anti-TIGIT Antibody Market Size by Regions (2019-2024)
4.2 Americas Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.3 APAC Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.4 Europe Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa Anti-TIGIT Antibody Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-TIGIT Antibody Market Size by Country (2019-2024)
5.2 Americas Anti-TIGIT Antibody Market Size by Type (2019-2024)
5.3 Americas Anti-TIGIT Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-TIGIT Antibody Market Size by Region (2019-2024)
6.2 APAC Anti-TIGIT Antibody Market Size by Type (2019-2024)
6.3 APAC Anti-TIGIT Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-TIGIT Antibody by Country (2019-2024)
7.2 Europe Anti-TIGIT Antibody Market Size by Type (2019-2024)
7.3 Europe Anti-TIGIT Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-TIGIT Antibody by Region (2019-2024)
8.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TIGIT ANTIBODY MARKET FORECAST
10.1 Global Anti-TIGIT Antibody Forecast by Regions (2025-2030)
10.1.1 Global Anti-TIGIT Antibody Forecast by Regions (2025-2030)
10.1.2 Americas Anti-TIGIT Antibody Forecast
10.1.3 APAC Anti-TIGIT Antibody Forecast
10.1.4 Europe Anti-TIGIT Antibody Forecast
10.1.5 Middle East & Africa Anti-TIGIT Antibody Forecast
10.2 Americas Anti-TIGIT Antibody Forecast by Country (2025-2030)
10.2.1 United States Anti-TIGIT Antibody Market Forecast
10.2.2 Canada Anti-TIGIT Antibody Market Forecast
10.2.3 Mexico Anti-TIGIT Antibody Market Forecast
10.2.4 Brazil Anti-TIGIT Antibody Market Forecast
10.3 APAC Anti-TIGIT Antibody Forecast by Region (2025-2030)
10.3.1 China Anti-TIGIT Antibody Market Forecast
10.3.2 Japan Anti-TIGIT Antibody Market Forecast
10.3.3 Korea Anti-TIGIT Antibody Market Forecast
10.3.4 Southeast Asia Anti-TIGIT Antibody Market Forecast
10.3.5 India Anti-TIGIT Antibody Market Forecast
10.3.6 Australia Anti-TIGIT Antibody Market Forecast
10.4 Europe Anti-TIGIT Antibody Forecast by Country (2025-2030)
10.4.1 Germany Anti-TIGIT Antibody Market Forecast
10.4.2 France Anti-TIGIT Antibody Market Forecast
10.4.3 UK Anti-TIGIT Antibody Market Forecast
10.4.4 Italy Anti-TIGIT Antibody Market Forecast
10.4.5 Russia Anti-TIGIT Antibody Market Forecast
10.5 Middle East & Africa Anti-TIGIT Antibody Forecast by Region (2025-2030)
10.5.1 Egypt Anti-TIGIT Antibody Market Forecast
10.5.2 South Africa Anti-TIGIT Antibody Market Forecast
10.5.3 Israel Anti-TIGIT Antibody Market Forecast
10.5.4 Turkey Anti-TIGIT Antibody Market Forecast
10.5.5 GCC Countries Anti-TIGIT Antibody Market Forecast
10.6 Global Anti-TIGIT Antibody Forecast by Type (2025-2030)
10.7 Global Anti-TIGIT Antibody Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anti-TIGIT Antibody Product Offered
11.1.3 Roche Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Anti-TIGIT Antibody Product Offered
11.2.3 Merck Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Anti-TIGIT Antibody Product Offered
11.3.3 AstraZeneca Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Arcus
11.4.1 Arcus Company Information
11.4.2 Arcus Anti-TIGIT Antibody Product Offered
11.4.3 Arcus Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arcus Main Business Overview
11.4.5 Arcus Latest Developments
11.5 Astellas
11.5.1 Astellas Company Information
11.5.2 Astellas Anti-TIGIT Antibody Product Offered
11.5.3 Astellas Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Astellas Main Business Overview
11.5.5 Astellas Latest Developments
11.6 BeiGene
11.6.1 BeiGene Company Information
11.6.2 BeiGene Anti-TIGIT Antibody Product Offered
11.6.3 BeiGene Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BeiGene Main Business Overview
11.6.5 BeiGene Latest Developments
11.7 BMS
11.7.1 BMS Company Information
11.7.2 BMS Anti-TIGIT Antibody Product Offered
11.7.3 BMS Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BMS Main Business Overview
11.7.5 BMS Latest Developments
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Information
11.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Offered
11.8.3 Junshi Biosciences Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Junshi Biosciences Main Business Overview
11.8.5 Junshi Biosciences Latest Developments
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Information
11.9.2 Innovent Biologics Anti-TIGIT Antibody Product Offered
11.9.3 Innovent Biologics Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Innovent Biologics Main Business Overview
11.9.5 Innovent Biologics Latest Developments
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Information
11.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Offered
11.10.3 Mereo BioPharma Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mereo BioPharma Main Business Overview
11.10.5 Mereo BioPharma Latest Developments
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Information
11.11.2 Seattle Genetics Anti-TIGIT Antibody Product Offered
11.11.3 Seattle Genetics Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seattle Genetics Main Business Overview
11.11.5 Seattle Genetics Latest Developments
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Information
11.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Offered
11.12.3 Hengrui Medicine Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hengrui Medicine Main Business Overview
11.12.5 Hengrui Medicine Latest Developments
11.13 Compugen
11.13.1 Compugen Company Information
11.13.2 Compugen Anti-TIGIT Antibody Product Offered
11.13.3 Compugen Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Compugen Main Business Overview
11.13.5 Compugen Latest Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Information
11.14.2 Gilead Sciences Anti-TIGIT Antibody Product Offered
11.14.3 Gilead Sciences Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Gilead Sciences Main Business Overview
11.14.5 Gilead Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size 2019-2030
2.1.2 Anti-TIGIT Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Anti-TIGIT Antibody Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Anti-TIGIT Antibody Market Size by Type
2.3.1 Anti-TIGIT Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
2.4 Anti-TIGIT Antibody Segment by Application
2.4.1 Cell Carcinoma
2.4.2 Solid Tumor
2.5 Anti-TIGIT Antibody Market Size by Application
2.5.1 Anti-TIGIT Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
3 ANTI-TIGIT ANTIBODY MARKET SIZE BY PLAYER
3.1 Anti-TIGIT Antibody Market Size Market Share by Players
3.1.1 Global Anti-TIGIT Antibody Revenue by Players (2019-2024)
3.1.2 Global Anti-TIGIT Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Anti-TIGIT Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY BY REGIONS
4.1 Anti-TIGIT Antibody Market Size by Regions (2019-2024)
4.2 Americas Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.3 APAC Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.4 Europe Anti-TIGIT Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa Anti-TIGIT Antibody Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-TIGIT Antibody Market Size by Country (2019-2024)
5.2 Americas Anti-TIGIT Antibody Market Size by Type (2019-2024)
5.3 Americas Anti-TIGIT Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-TIGIT Antibody Market Size by Region (2019-2024)
6.2 APAC Anti-TIGIT Antibody Market Size by Type (2019-2024)
6.3 APAC Anti-TIGIT Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-TIGIT Antibody by Country (2019-2024)
7.2 Europe Anti-TIGIT Antibody Market Size by Type (2019-2024)
7.3 Europe Anti-TIGIT Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-TIGIT Antibody by Region (2019-2024)
8.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TIGIT ANTIBODY MARKET FORECAST
10.1 Global Anti-TIGIT Antibody Forecast by Regions (2025-2030)
10.1.1 Global Anti-TIGIT Antibody Forecast by Regions (2025-2030)
10.1.2 Americas Anti-TIGIT Antibody Forecast
10.1.3 APAC Anti-TIGIT Antibody Forecast
10.1.4 Europe Anti-TIGIT Antibody Forecast
10.1.5 Middle East & Africa Anti-TIGIT Antibody Forecast
10.2 Americas Anti-TIGIT Antibody Forecast by Country (2025-2030)
10.2.1 United States Anti-TIGIT Antibody Market Forecast
10.2.2 Canada Anti-TIGIT Antibody Market Forecast
10.2.3 Mexico Anti-TIGIT Antibody Market Forecast
10.2.4 Brazil Anti-TIGIT Antibody Market Forecast
10.3 APAC Anti-TIGIT Antibody Forecast by Region (2025-2030)
10.3.1 China Anti-TIGIT Antibody Market Forecast
10.3.2 Japan Anti-TIGIT Antibody Market Forecast
10.3.3 Korea Anti-TIGIT Antibody Market Forecast
10.3.4 Southeast Asia Anti-TIGIT Antibody Market Forecast
10.3.5 India Anti-TIGIT Antibody Market Forecast
10.3.6 Australia Anti-TIGIT Antibody Market Forecast
10.4 Europe Anti-TIGIT Antibody Forecast by Country (2025-2030)
10.4.1 Germany Anti-TIGIT Antibody Market Forecast
10.4.2 France Anti-TIGIT Antibody Market Forecast
10.4.3 UK Anti-TIGIT Antibody Market Forecast
10.4.4 Italy Anti-TIGIT Antibody Market Forecast
10.4.5 Russia Anti-TIGIT Antibody Market Forecast
10.5 Middle East & Africa Anti-TIGIT Antibody Forecast by Region (2025-2030)
10.5.1 Egypt Anti-TIGIT Antibody Market Forecast
10.5.2 South Africa Anti-TIGIT Antibody Market Forecast
10.5.3 Israel Anti-TIGIT Antibody Market Forecast
10.5.4 Turkey Anti-TIGIT Antibody Market Forecast
10.5.5 GCC Countries Anti-TIGIT Antibody Market Forecast
10.6 Global Anti-TIGIT Antibody Forecast by Type (2025-2030)
10.7 Global Anti-TIGIT Antibody Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anti-TIGIT Antibody Product Offered
11.1.3 Roche Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Anti-TIGIT Antibody Product Offered
11.2.3 Merck Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Anti-TIGIT Antibody Product Offered
11.3.3 AstraZeneca Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Arcus
11.4.1 Arcus Company Information
11.4.2 Arcus Anti-TIGIT Antibody Product Offered
11.4.3 Arcus Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arcus Main Business Overview
11.4.5 Arcus Latest Developments
11.5 Astellas
11.5.1 Astellas Company Information
11.5.2 Astellas Anti-TIGIT Antibody Product Offered
11.5.3 Astellas Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Astellas Main Business Overview
11.5.5 Astellas Latest Developments
11.6 BeiGene
11.6.1 BeiGene Company Information
11.6.2 BeiGene Anti-TIGIT Antibody Product Offered
11.6.3 BeiGene Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BeiGene Main Business Overview
11.6.5 BeiGene Latest Developments
11.7 BMS
11.7.1 BMS Company Information
11.7.2 BMS Anti-TIGIT Antibody Product Offered
11.7.3 BMS Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BMS Main Business Overview
11.7.5 BMS Latest Developments
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Information
11.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Offered
11.8.3 Junshi Biosciences Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Junshi Biosciences Main Business Overview
11.8.5 Junshi Biosciences Latest Developments
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Information
11.9.2 Innovent Biologics Anti-TIGIT Antibody Product Offered
11.9.3 Innovent Biologics Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Innovent Biologics Main Business Overview
11.9.5 Innovent Biologics Latest Developments
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Information
11.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Offered
11.10.3 Mereo BioPharma Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mereo BioPharma Main Business Overview
11.10.5 Mereo BioPharma Latest Developments
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Information
11.11.2 Seattle Genetics Anti-TIGIT Antibody Product Offered
11.11.3 Seattle Genetics Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seattle Genetics Main Business Overview
11.11.5 Seattle Genetics Latest Developments
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Information
11.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Offered
11.12.3 Hengrui Medicine Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hengrui Medicine Main Business Overview
11.12.5 Hengrui Medicine Latest Developments
11.13 Compugen
11.13.1 Compugen Company Information
11.13.2 Compugen Anti-TIGIT Antibody Product Offered
11.13.3 Compugen Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Compugen Main Business Overview
11.13.5 Compugen Latest Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Information
11.14.2 Gilead Sciences Anti-TIGIT Antibody Product Offered
11.14.3 Gilead Sciences Anti-TIGIT Antibody Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Gilead Sciences Main Business Overview
11.14.5 Gilead Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Anti-TIGIT Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 7. Anti-TIGIT Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 10. Global Anti-TIGIT Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Anti-TIGIT Antibody Revenue Market Share by Player (2019-2024)
Table 12. Anti-TIGIT Antibody Key Players Head office and Products Offered
Table 13. Anti-TIGIT Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti-TIGIT Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Anti-TIGIT Antibody Market Size Market Share by Regions (2019-2024)
Table 18. Global Anti-TIGIT Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Anti-TIGIT Antibody Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Anti-TIGIT Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Anti-TIGIT Antibody Market Size Market Share by Country (2019-2024)
Table 22. Americas Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 24. Americas Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 26. APAC Anti-TIGIT Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Table 28. APAC Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 30. APAC Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 32. Europe Anti-TIGIT Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Anti-TIGIT Antibody Market Size Market Share by Country (2019-2024)
Table 34. Europe Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 36. Europe Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Anti-TIGIT Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Anti-TIGIT Antibody
Table 45. Key Market Challenges & Risks of Anti-TIGIT Antibody
Table 46. Key Industry Trends of Anti-TIGIT Antibody
Table 47. Global Anti-TIGIT Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Roche Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 52. Roche Anti-TIGIT Antibody Product Offered
Table 53. Roche Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Merck Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 57. Merck Anti-TIGIT Antibody Product Offered
Table 58. Merck Main Business
Table 59. Merck Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Merck Latest Developments
Table 61. AstraZeneca Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 62. AstraZeneca Anti-TIGIT Antibody Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Arcus Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 67. Arcus Anti-TIGIT Antibody Product Offered
Table 68. Arcus Main Business
Table 69. Arcus Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arcus Latest Developments
Table 71. Astellas Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 72. Astellas Anti-TIGIT Antibody Product Offered
Table 73. Astellas Main Business
Table 74. Astellas Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Astellas Latest Developments
Table 76. BeiGene Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 77. BeiGene Anti-TIGIT Antibody Product Offered
Table 78. BeiGene Main Business
Table 79. BeiGene Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BeiGene Latest Developments
Table 81. BMS Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 82. BMS Anti-TIGIT Antibody Product Offered
Table 83. BMS Main Business
Table 84. BMS Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. BMS Latest Developments
Table 86. Junshi Biosciences Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 87. Junshi Biosciences Anti-TIGIT Antibody Product Offered
Table 88. Junshi Biosciences Main Business
Table 89. Junshi Biosciences Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Junshi Biosciences Latest Developments
Table 91. Innovent Biologics Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 92. Innovent Biologics Anti-TIGIT Antibody Product Offered
Table 93. Innovent Biologics Main Business
Table 94. Innovent Biologics Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Innovent Biologics Latest Developments
Table 96. Mereo BioPharma Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 97. Mereo BioPharma Anti-TIGIT Antibody Product Offered
Table 98. Mereo BioPharma Main Business
Table 99. Mereo BioPharma Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Mereo BioPharma Latest Developments
Table 101. Seattle Genetics Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 102. Seattle Genetics Anti-TIGIT Antibody Product Offered
Table 103. Seattle Genetics Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Seattle Genetics Main Business
Table 105. Seattle Genetics Latest Developments
Table 106. Hengrui Medicine Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 107. Hengrui Medicine Anti-TIGIT Antibody Product Offered
Table 108. Hengrui Medicine Main Business
Table 109. Hengrui Medicine Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Hengrui Medicine Latest Developments
Table 111. Compugen Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 112. Compugen Anti-TIGIT Antibody Product Offered
Table 113. Compugen Main Business
Table 114. Compugen Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Compugen Latest Developments
Table 116. Gilead Sciences Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 117. Gilead Sciences Anti-TIGIT Antibody Product Offered
Table 118. Gilead Sciences Main Business
Table 119. Gilead Sciences Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Gilead Sciences Latest Developments
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Anti-TIGIT Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 7. Anti-TIGIT Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 10. Global Anti-TIGIT Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Anti-TIGIT Antibody Revenue Market Share by Player (2019-2024)
Table 12. Anti-TIGIT Antibody Key Players Head office and Products Offered
Table 13. Anti-TIGIT Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti-TIGIT Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Anti-TIGIT Antibody Market Size Market Share by Regions (2019-2024)
Table 18. Global Anti-TIGIT Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Anti-TIGIT Antibody Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Anti-TIGIT Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Anti-TIGIT Antibody Market Size Market Share by Country (2019-2024)
Table 22. Americas Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 24. Americas Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 26. APAC Anti-TIGIT Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Table 28. APAC Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 30. APAC Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 32. Europe Anti-TIGIT Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Anti-TIGIT Antibody Market Size Market Share by Country (2019-2024)
Table 34. Europe Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 36. Europe Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Anti-TIGIT Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Anti-TIGIT Antibody
Table 45. Key Market Challenges & Risks of Anti-TIGIT Antibody
Table 46. Key Industry Trends of Anti-TIGIT Antibody
Table 47. Global Anti-TIGIT Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Roche Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 52. Roche Anti-TIGIT Antibody Product Offered
Table 53. Roche Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Merck Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 57. Merck Anti-TIGIT Antibody Product Offered
Table 58. Merck Main Business
Table 59. Merck Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Merck Latest Developments
Table 61. AstraZeneca Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 62. AstraZeneca Anti-TIGIT Antibody Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Arcus Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 67. Arcus Anti-TIGIT Antibody Product Offered
Table 68. Arcus Main Business
Table 69. Arcus Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arcus Latest Developments
Table 71. Astellas Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 72. Astellas Anti-TIGIT Antibody Product Offered
Table 73. Astellas Main Business
Table 74. Astellas Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Astellas Latest Developments
Table 76. BeiGene Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 77. BeiGene Anti-TIGIT Antibody Product Offered
Table 78. BeiGene Main Business
Table 79. BeiGene Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BeiGene Latest Developments
Table 81. BMS Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 82. BMS Anti-TIGIT Antibody Product Offered
Table 83. BMS Main Business
Table 84. BMS Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. BMS Latest Developments
Table 86. Junshi Biosciences Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 87. Junshi Biosciences Anti-TIGIT Antibody Product Offered
Table 88. Junshi Biosciences Main Business
Table 89. Junshi Biosciences Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Junshi Biosciences Latest Developments
Table 91. Innovent Biologics Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 92. Innovent Biologics Anti-TIGIT Antibody Product Offered
Table 93. Innovent Biologics Main Business
Table 94. Innovent Biologics Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Innovent Biologics Latest Developments
Table 96. Mereo BioPharma Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 97. Mereo BioPharma Anti-TIGIT Antibody Product Offered
Table 98. Mereo BioPharma Main Business
Table 99. Mereo BioPharma Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Mereo BioPharma Latest Developments
Table 101. Seattle Genetics Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 102. Seattle Genetics Anti-TIGIT Antibody Product Offered
Table 103. Seattle Genetics Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Seattle Genetics Main Business
Table 105. Seattle Genetics Latest Developments
Table 106. Hengrui Medicine Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 107. Hengrui Medicine Anti-TIGIT Antibody Product Offered
Table 108. Hengrui Medicine Main Business
Table 109. Hengrui Medicine Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Hengrui Medicine Latest Developments
Table 111. Compugen Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 112. Compugen Anti-TIGIT Antibody Product Offered
Table 113. Compugen Main Business
Table 114. Compugen Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Compugen Latest Developments
Table 116. Gilead Sciences Details, Company Type, Anti-TIGIT Antibody Area Served and Its Competitors
Table 117. Gilead Sciences Anti-TIGIT Antibody Product Offered
Table 118. Gilead Sciences Main Business
Table 119. Gilead Sciences Anti-TIGIT Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Gilead Sciences Latest Developments
LIST OF FIGURES
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-TIGIT Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Anti-TIGIT Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-TIGIT Antibody Sales Market Share by Country/Region (2023)
Figure 8. Anti-TIGIT Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-TIGIT Antibody Market Size Market Share by Type in 2023
Figure 10. Anti-TIGIT Antibody in Cell Carcinoma
Figure 11. Global Anti-TIGIT Antibody Market: Cell Carcinoma (2019-2024) & ($ Millions)
Figure 12. Anti-TIGIT Antibody in Solid Tumor
Figure 13. Global Anti-TIGIT Antibody Market: Solid Tumor (2019-2024) & ($ Millions)
Figure 14. Global Anti-TIGIT Antibody Market Size Market Share by Application in 2023
Figure 15. Global Anti-TIGIT Antibody Revenue Market Share by Player in 2023
Figure 16. Global Anti-TIGIT Antibody Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 18. APAC Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 19. Europe Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Americas Anti-TIGIT Antibody Value Market Share by Country in 2023
Figure 22. United States Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Anti-TIGIT Antibody Market Size Market Share by Region in 2023
Figure 27. APAC Anti-TIGIT Antibody Market Size Market Share by Type in 2023
Figure 28. APAC Anti-TIGIT Antibody Market Size Market Share by Application in 2023
Figure 29. China Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Anti-TIGIT Antibody Market Size Market Share by Country in 2023
Figure 36. Europe Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Figure 37. Europe Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Figure 38. Germany Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 52. APAC Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 53. Europe Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 55. United States Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Canada Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 59. China Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Japan Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 61. Korea Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 63. India Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Australia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 65. Germany Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 66. France Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 67. UK Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 68. Italy Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 69. Russia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Spain Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Israel Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Application (2025-2030)
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-TIGIT Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Anti-TIGIT Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-TIGIT Antibody Sales Market Share by Country/Region (2023)
Figure 8. Anti-TIGIT Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-TIGIT Antibody Market Size Market Share by Type in 2023
Figure 10. Anti-TIGIT Antibody in Cell Carcinoma
Figure 11. Global Anti-TIGIT Antibody Market: Cell Carcinoma (2019-2024) & ($ Millions)
Figure 12. Anti-TIGIT Antibody in Solid Tumor
Figure 13. Global Anti-TIGIT Antibody Market: Solid Tumor (2019-2024) & ($ Millions)
Figure 14. Global Anti-TIGIT Antibody Market Size Market Share by Application in 2023
Figure 15. Global Anti-TIGIT Antibody Revenue Market Share by Player in 2023
Figure 16. Global Anti-TIGIT Antibody Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 18. APAC Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 19. Europe Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Anti-TIGIT Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Americas Anti-TIGIT Antibody Value Market Share by Country in 2023
Figure 22. United States Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Anti-TIGIT Antibody Market Size Market Share by Region in 2023
Figure 27. APAC Anti-TIGIT Antibody Market Size Market Share by Type in 2023
Figure 28. APAC Anti-TIGIT Antibody Market Size Market Share by Application in 2023
Figure 29. China Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Anti-TIGIT Antibody Market Size Market Share by Country in 2023
Figure 36. Europe Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Figure 37. Europe Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Figure 38. Germany Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Anti-TIGIT Antibody Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Anti-TIGIT Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 52. APAC Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 53. Europe Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 55. United States Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Canada Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 59. China Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Japan Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 61. Korea Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 63. India Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Australia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 65. Germany Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 66. France Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 67. UK Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 68. Italy Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 69. Russia Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Spain Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Israel Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Anti-TIGIT Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Anti-TIGIT Antibody Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Cell Spreaders Market Growth 2023-2029
US$ 3,660.00
March 2023
114 pages
Global Audiology Service Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
92 pages
Global Albumin (as Excipient) Market Growth 2025-2031
US$ 3,660.00
January 2025
122 pages
Global Liposuction Surgical Procedures Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
100 pages
